Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

2,268 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Hydroxychloroquine lowers Alzheimer's disease and related dementias risk and rescues molecular phenotypes related to Alzheimer's disease.
Varma VR, Desai RJ, Navakkode S, Wong LW, Anerillas C, Loeffler T, Schilcher I, Mahesri M, Chin K, Horton DB, Kim SC, Gerhard T, Segal JB, Schneeweiss S, Gorospe M, Sajikumar S, Thambisetty M. Varma VR, et al. Among authors: chin k. Mol Psychiatry. 2023 Mar;28(3):1312-1326. doi: 10.1038/s41380-022-01912-0. Epub 2022 Dec 28. Mol Psychiatry. 2023. PMID: 36577843 Free PMC article.
Comparative Risk of Alzheimer Disease and Related Dementia Among Medicare Beneficiaries With Rheumatoid Arthritis Treated With Targeted Disease-Modifying Antirheumatic Agents.
Desai RJ, Varma VR, Gerhard T, Segal J, Mahesri M, Chin K, Horton DB, Kim SC, Schneeweiss S, Thambisetty M. Desai RJ, et al. Among authors: chin k. JAMA Netw Open. 2022 Apr 1;5(4):e226567. doi: 10.1001/jamanetworkopen.2022.6567. JAMA Netw Open. 2022. PMID: 35394510 Free PMC article.
Targeting abnormal metabolism in Alzheimer's disease: The Drug Repurposing for Effective Alzheimer's Medicines (DREAM) study.
Desai RJ, Varma VR, Gerhard T, Segal J, Mahesri M, Chin K, Nonnenmacher E, Gabbeta A, Mammen AM, Varma S, Horton DB, Kim SC, Schneeweiss S, Thambisetty M. Desai RJ, et al. Among authors: chin k. Alzheimers Dement (N Y). 2020 Nov 26;6(1):e12095. doi: 10.1002/trc2.12095. eCollection 2020. Alzheimers Dement (N Y). 2020. PMID: 33304987 Free PMC article.
Sodium-Glucose Cotransporter-2 Inhibitors Versus Glucagon-like Peptide-1 Receptor Agonists and the Risk for Cardiovascular Outcomes in Routine Care Patients With Diabetes Across Categories of Cardiovascular Disease.
Patorno E, Htoo PT, Glynn RJ, Schneeweiss S, Wexler DJ, Pawar A, Bessette LG, Chin K, Everett BM, Kim SC. Patorno E, et al. Among authors: chin k. Ann Intern Med. 2022 Jan;175(1):W4-W5. doi: 10.7326/L21-0709. Ann Intern Med. 2022. PMID: 35038404 No abstract available.
Sodium-Glucose Cotransporter-2 Inhibitors Versus Glucagon-like Peptide-1 Receptor Agonists and the Risk for Cardiovascular Outcomes in Routine Care Patients With Diabetes Across Categories of Cardiovascular Disease.
Patorno E, Htoo PT, Glynn RJ, Schneeweiss S, Wexler DJ, Pawar A, Bessette LG, Chin K, Everett BM, Kim SC. Patorno E, et al. Among authors: chin k. Ann Intern Med. 2021 Nov;174(11):1528-1541. doi: 10.7326/M21-0893. Epub 2021 Sep 28. Ann Intern Med. 2021. PMID: 34570599 Free PMC article.
2,268 results